MEDIZINISCHES LASERZENTRUM LUBECK GMBH

Their core work

MLL GmbH is a medical laser research center based in Lübeck, Germany, specializing in advanced optical and photonic technologies for biomedical applications. They develop laser-based imaging and diagnostic tools — including multiphoton microscopy and infrared spectroscopy — and work to translate these from laboratory prototypes into clinical use. Their work spans ophthalmic microsurgery robotics, corneal regeneration therapies, and fast infrared microscopy for tissue analysis, positioning them at the intersection of photonics engineering and medical diagnostics.

What they specialise in

How they've shifted over time

MLL's early H2020 work (2015-2018) focused on applying laser and optical expertise to specific medical procedures — robotic eye surgery and corneal therapies — where they contributed as a specialist partner or third party. Their most recent and largest project (FAIR CHARM, 2022-2026) marks a significant shift toward fundamental imaging technology development, specifically multiphoton microscopy in the short-wave infrared range, with an explicit goal of clinical translation. This evolution suggests a move from supporting role in application-driven projects to a more central position in developing next-generation diagnostic imaging platforms.

MLL is shifting from niche surgical applications toward building broad-use infrared imaging platforms for clinical diagnostics — a higher-impact, more scalable direction.

How they like to work

MLL has never coordinated an H2020 project, consistently joining as a participant or third party, which reflects a specialist contributor model — they bring deep laser/photonics expertise to consortia led by others. With 30 unique partners across 12 countries from just 3 projects, they work in mid-to-large consortia and are clearly comfortable in international, multi-partner settings. Their role pattern suggests they are valued for specific technical capabilities rather than project management or coordination.

Despite only three projects, MLL has built a broad network of 30 partners across 12 countries, indicating participation in large European consortia with diverse membership. Their network spans both the medical device and advanced optics communities.

What sets them apart

MLL occupies a rare niche as a research SME that bridges medical laser engineering and clinical application — most laser centers are either purely academic or purely industrial. Their Lübeck base places them in one of Germany's strongest biophotonics clusters, with direct access to the University of Lübeck medical campus. For consortium builders, they offer hands-on photonics development capability with a track record of working in regulated medical contexts, without the overhead of a large institutional partner.

Highlights from their portfolio

• FAIR CHARM
  Their largest project by far (EUR 1M+), focused on next-generation infrared microscopy — represents their current strategic direction and strongest funding commitment.
• EurEyeCase
  An early project combining robotics with ophthalmic microsurgery, demonstrating MLL's ability to contribute laser expertise to complex interdisciplinary medical device projects.